Home Newsfeeds CNBC Halftime Report Final Trades: General Electric, Wynn Resorts & Shake Shack

CNBC Halftime Report Final Trades: General Electric, Wynn Resorts & Shake Shack

– CNBC

byBenzinga Newsdesk

October 25, 2022

1 minute read

– CNBC

Morgan Stanley Maintains Equal-Weight on Kymera Therapeutics, Raises Price Target to $37

By Benzinga Newsdesk

August 29, 9:24 AM

Morgan Stanley analyst Vikram Purohit maintains Kymera Therapeutics (NASDAQ:KYMR) with a Equal-Weight and raises the price target from $35 to $37.

KYMR

Can Psychedelics Therapy Be Reimbursed? AMA Releases Details On Coding These Procedures

By Lara Goldstein

July 6, 1:47 PM

The American Medical Association (AMA) published language concerning the recently-approved Current Procedural Terminology (CPT) III codes applying to psychedelic-assisted therapies, as announced by its

CMPS

Amneal Launches PEMRYDI RTU, The First Ready-To-Use Version Of Important Oncology Injectable Medicine

By Benzinga Newsdesk

April 16, 8:16 AM

Novel 505(b)(2) presentation of a key injectable for treating non-squamous non-small cell lung cancer and malignant pleural mesothelioma, does not require reconstitution, dilution, or refrigerationAmneal plans to launch

AMRX

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,600 Today

By Benzinga Insights

September 16, 1:01 PM

Shopify (NYSE:SHOP) has outperformed the market over the past 5 years by 12.28% on an annualized basis producing an average annual return of 21.18%. Currently, Shopify has a market capitalization of $40.75 billion.

SHOP

CNBC Halftime Report Final Trades: General Electric, Wynn Resorts & Shake Shack

Related Posts

Morgan Stanley Maintains Equal-Weight on Kymera Therapeutics, Raises Price Target to $37

Can Psychedelics Therapy Be Reimbursed? AMA Releases Details On Coding These Procedures

Amneal Launches PEMRYDI RTU, The First Ready-To-Use Version Of Important Oncology Injectable Medicine

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,600 Today